Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

"Abzena and Mabqi partner for drug development solution" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

The goal of the project is to develop novel approaches that strengthen and reduce the costs of domestic mAb biomanufacturing to protect against and treat infection by filoviruses.

Today, NIIMBL (the National Institute for Innovation in Manufacturing Biopharmaceuticals) announced that a NIIMBL-led team will receive $10.5 Million in funding through the Gates Grand Challenges ...

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing fully human antibodies, formed a strategic partnership.

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), announces a manufacturing contract ...

DURHAM, N.C.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb™, an offering built on the robustness of KBI’s SUREtechnology Platform™, ...

Ginkgo Bioworks Holdings, Inc. (($DNA)) has held its Q3 earnings call. Read on for the main highlights of the call. Ginkgo Bioworks Holdings, Inc.

This eBook explores recent developments in purification and polishing, highlighting strategies that streamline processing, ...

Researchers at the Terasaki Institute developed a novel microfluidic biosensing platform to monitor monoclonal antibody secretion in real time. The system integrates a photonic crystal biosensor with ...

The state-of-the-art manufacturing plant has a significantly smaller footprint than the conventional manufacturing facilities. Enzene is amongst the first movers in end-to-end connected bio ...

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time drug developer, Indian CRDMO Syngene International is capitalizing on the ...